These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30221004)

  • 1. Time-lapse live cell imaging to monitor doxorubicin release from DNA origami nanostructures.
    Zeng Y; Liu J; Yang S; Liu W; Xu L; Wang R
    J Mater Chem B; 2018 Mar; 6(11):1605-1612. PubMed ID: 30221004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Functional Properties of Three DNA Origami Nanostructures as Doxorubicin Carriers to Breast Cancer Cells.
    Udomprasert A; Wootthichairangsan C; Duangrat R; Chaithongyot S; Zhang Y; Nixon R; Liu W; Wang R; Ponglikitmongkol M; Kangsamaksin T
    ACS Appl Bio Mater; 2022 May; 5(5):2262-2272. PubMed ID: 35500214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA origami as an in vivo drug delivery vehicle for cancer therapy.
    Zhang Q; Jiang Q; Li N; Dai L; Liu Q; Song L; Wang J; Li Y; Tian J; Ding B; Du Y
    ACS Nano; 2014 Jul; 8(7):6633-43. PubMed ID: 24963790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
    Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
    Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-Incorporated Nanotherapeutic Delivery System Based on Gelatin-Coated Gold Nanoparticles: Formulation, Drug Release, and Multimodal Imaging of Cellular Internalization.
    Suarasan S; Focsan M; Potara M; Soritau O; Florea A; Maniu D; Astilean S
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22900-13. PubMed ID: 27537061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect.
    Wiradharma N; Tong YW; Yang YY
    Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
    Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
    Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
    Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
    Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA origami as a carrier for circumvention of drug resistance.
    Jiang Q; Song C; Nangreave J; Liu X; Lin L; Qiu D; Wang ZG; Zou G; Liang X; Yan H; Ding B
    J Am Chem Soc; 2012 Aug; 134(32):13396-403. PubMed ID: 22803823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs.
    Kundu A; Nandi S; Das P; Nandi AK
    ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
    Liu X; Wu L; Wang L; Jiang W
    Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA origami delivery system for cancer therapy with tunable release properties.
    Zhao YX; Shaw A; Zeng X; Benson E; Nyström AM; Högberg B
    ACS Nano; 2012 Oct; 6(10):8684-91. PubMed ID: 22950811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical characterisation of DNA origami nanostructures reveals inaccessibility to intercalation binding sites.
    Miller HL; Contera S; Wollman AJM; Hirst A; Dunn KE; Schröter S; O'Connell D; Leake MC
    Nanotechnology; 2020 Mar; 31(23):235605. PubMed ID: 32125281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    He Y; Su Z; Xue L; Xu H; Zhang C
    J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-infrared light remote-controlled intracellular anti-cancer drug delivery using thermo/pH sensitive nanovehicle.
    Qin Y; Chen J; Bi Y; Xu X; Zhou H; Gao J; Hu Y; Zhao Y; Chai Z
    Acta Biomater; 2015 Apr; 17():201-9. PubMed ID: 25644449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-Assembled DNA Nanocentipede as Multivalent Drug Carrier for Targeted Delivery.
    Li W; Yang X; He L; Wang K; Wang Q; Huang J; Liu J; Wu B; Xu C
    ACS Appl Mater Interfaces; 2016 Oct; 8(39):25733-25740. PubMed ID: 27622459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific anchoring aptamer C2NP on DNA origami nanostructures for cancer treatment.
    Sun P; Zhang N; Tang Y; Yang Y; Zhou J; Zhao Y
    RSC Adv; 2018 Jul; 8(46):26300-26308. PubMed ID: 35541930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.